BAO PHARMA-B(02659.HK) closed 9.16% higher, closing at HKD 27.4
Tags：
- BAO PHARMA-B (02659.HK): IND for KJ015 injection (anti-HER2 bispecific antibody subcutaneous formulation) approved by US FDA
- BAO PHARMA-B(02659.HK): Subcutaneous Infusion Ceftriaxone Sodium BJ007 FDA IND Approval
- Shanghai Bao Pharmaceuticals(02659.HK): IND Application for Injection BJ044 Approved by NMPA
